Medicare Enrolled
Dr. Nizar Eskandar, M.D.
Internal Medicine · Hinesville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Eskandar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eskandar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Eskandar
Dr. Nizar Eskandar is an internal medicine specialist in Hinesville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Eskandar performed 16,307 Medicare services across 8,127 unique beneficiaries.
Between the years covered by Open Payments, Dr. Eskandar received a total of $9,959 from 47 pharmaceutical and/or device companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Eskandar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in GA
$9,959 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,307
Medicare services
Top 1% in GA for internal medicine
8,127
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~858 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
2,364 | $92 | $261 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,962 | $85 | $270 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,576 | $61 | $181 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
700 | $8 | $18 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
630 | $10 | $43 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
600 | $7 | $32 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
587 | $7 | $27 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
581 | $5 | $19 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
544 | $5 | $21 |
| Urine total protein level A laboratory test that measures the total amount of protein present in a urine sample. |
518 | $4 | $15 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
510 | $6 | $24 |
| Urinalysis, microscopic examination A laboratory test that examines a urine sample under a microscope to check for cells, crystals, bacteria, or other substances. |
508 | $3 | $12 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
483 | $262 | $862 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
468 | $131 | $511 |
| Dialysis services, partial month (age 20+) Dialysis treatment provided for a partial month of service for patients aged 20 years or older. |
458 | $7 | $24 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
402 | $40 | $169 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
296 | $55 | $221 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
262 | $16 | $69 |
| Dialysis procedure with evaluation A dialysis treatment that includes one evaluation. |
253 | $65 | $261 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
249 | $9 | $37 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
236 | $77 | $271 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
222 | $9 | $40 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
186 | $226 | $727 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
179 | $196 | $725 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
178 | $4 | $18 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
153 | $6 | $27 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
150 | $13 | $56 |
| Iron level test | 149 | $6 | $26 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
149 | $9 | $36 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
136 | $3 | $11 |
| Monthly dialysis physician visit A monthly doctor's visit for patients aged 20 or older who are receiving dialysis treatment. |
87 | $154 | $629 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
86 | $13 | $55 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
83 | $15 | $62 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
80 | $14 | $60 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
80 | $167 | $688 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
73 | $66 | $183 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
66 | $2 | $9 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
32 | $29 | $121 |
| Urine sodium level test A laboratory test that measures the amount of sodium in a urine sample. This test helps evaluate electrolyte balance and kidney function. |
31 | $5 | $14 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,959
Total received (2018-2024)
Avg $1,423/year across 7 years
Top 8% in GA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
513
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,534 (95.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$425 (4.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,019
2023
$1,690
2022
$1,550
2021
$1,212
2020
$736
2019
$1,583
2018
$1,170
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$415
Otsuka America Pharmaceutical, Inc.
$294
Vifor Pharma, Inc.
$268
AstraZeneca Pharmaceuticals LP
$223
Travere Therapeutics, Inc.
$136
Aurinia Pharma U.S., Inc.
$134
OPKO Pharmaceuticals, LLC
$111
ANI Pharmaceuticals, Inc.
$71
Novartis Pharmaceuticals Corporation
$59
Ardelyx, Inc.
$45
Lilly USA, LLC
$35
Bayer Healthcare Pharmaceuticals Inc.
$34
Novo Nordisk Inc
$29
Boston Scientific Corporation
$29
Averitas Pharma Inc.
$26
AKEBIA THERAPEUTICS INC
$25
Mallinckrodt Hospital Products Inc.
$24
CALLIDITAS THERAPEUTICS US INC.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Paratek Pharmaceuticals, Inc.
$13
Sumitomo Pharma America, Inc.
$13
Top 3 companies account for 48.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,282
Horizon Therapeutics plc
$1,137
OPKO Pharmaceuticals, LLC
$940
Otsuka America Pharmaceutical, Inc.
$887
Vifor Pharma, Inc.
$847
AstraZeneca Pharmaceuticals LP
$742
Mallinckrodt Hospital Products Inc.
$526
Aurinia Pharma U.S., Inc.
$433
AKEBIA THERAPEUTICS INC
$347
Travere Therapeutics, Inc.
$309
Bayer Healthcare Pharmaceuticals Inc.
$258
Horizon Pharma plc
$235
Bayer HealthCare Pharmaceuticals Inc.
$217
Relypsa, Inc.
$201
Mallinckrodt Enterprises LLC
$180
Keryx Biopharmaceuticals, Inc.
$139
Novartis Pharmaceuticals Corporation
$125
Mallinckrodt LLC
$125
ANI Pharmaceuticals, Inc.
$106
Novo Nordisk Inc
$88
Fresenius USA Marketing, Inc.
$66
Shire North American Group Inc
$64
Merck Sharp & Dohme LLC
$60
Calliditas Therapeutics US Inc.
$54
Lilly USA, LLC
$48
CALLIDITAS THERAPEUTICS US INC.
$47
Ardelyx, Inc.
$45
Corcept Therapeutics
$45
Boston Scientific Corporation
$43
Ultragenyx Pharmaceutical Inc.
$36
Dexcom, Inc.
$32
BAXTER HEALTHCARE
$31
Dentsply Sirona Inc
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Averitas Pharma Inc.
$26
Pharmacosmos Therapeutics Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$20
Allergan Inc.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Retrophin, Inc.
$15
Arbor Pharmaceuticals, Inc.
$14
Paratek Pharmaceuticals, Inc.
$13
Sumitomo Pharma America, Inc.
$13
Daiichi Sankyo Inc.
$13
GlaxoSmithKline, LLC.
$13
ARBOR PHARMACEUTICALS, INC.
$13
Ironwood Pharmaceuticals, Inc
$11
Top 3 companies account for 33.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACTHAR · AURYXIA · Auryxia · BELSOMRA · BENLYSTA · CRYSVITA · Dexcom G6 Transmitter · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · Fabhalta · GATTEX · GEMTESA · GENERAL PAIN MANAGEMENT · IBSRELA · INJECTAFER · JANUVIA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · Korlym · LINZESS · LOKELMA · LUPKYNIS · MONOFERRIC · MOUNJARO · NATPARA · NATPARA (PARATHYROID HORMONE) · NUZYRA · Otezla · PURIFIED CORTROPHIN GEL · Parsabiv · QUTENZA · RAYALDEE · REXULTI · Rayaldee · Rayaldee (old) · Renal - PD · Repatha · Rybelsus · SAMSCA · SureSmile · TARPEYO · Tavneos · Thiola · VERQUVO · Vafseo · Velphoro · Veltassa · Wegovy · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for internal medicine in GA.
Geographic Context
Internal medicine physicians within 10 mi
38
Per 100K population
56.9
County median income
$59,013
Nearest hospital
LIBERTY REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Eskandar is a clinical cardiology specialist, with above-average Medicare volume (top 1% in GA), with low-engagement industry engagement in the top 8% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Eskandar experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Eskandar performed 2,364 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eskandar receive payments from pharmaceutical companies?
Yes. Dr. Eskandar received a total of $9,959 from 47 companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eskandar's costs compare to other internal medicine physicians in Hinesville?
Dr. Eskandar's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eskandar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Hinesville
Browse internal medicine physicians in Hinesville ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in GA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in GA
Which GA internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
OPKO Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from OPKO Pharmaceuticals, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology